Green Cross Health and Rako Science announce a nationwide COVID-19 PCR saliva testing partnership

Rako Science and Green Cross Health today announced a partnership to provide New Zealand employers and the public with nationwide access to non-invasive, highly accurate COVID-19 PCR saliva testing.


Rako Science is a molecular biology biotech business delivering COVID-19 PCR saliva testing to thousands of New Zealanders. Green Cross Health is a provider of primary health care services to communities through Unichem and Life Pharmacies, General Practices and Access Community Health.


“We are excited to partner with Green Cross Health and admire their commitment to improved customer health and wellbeing, which matches our value of increasing accessibility to new health services for all Kiwis,” Rako Science Director Leon Grice said.


Green Cross Health has an extensive network of more than 350 Unichem & Life pharmacies throughout the country focused on patient wellbeing by providing care and advice right into the heart of the communities. Rako Science deployed COVID-19 saliva testing in January and has a pipeline of innovations backed by its global strategic partners, University of Illinois, Victoria University of Wellington and global life sciences business, Thermo Fisher.


“Our pharmacy teams spend every day providing our patients and customers with vital healthcare services and advice, and our nationwide footprint means we provide support the length and breadth of New Zealand. We help Kiwis manage their healthcare and, more importantly, support them to stay well. We are excited to partner with Rako Science to bring this innovative precision medical service to New Zealanders” Stephen Jones, GM Equity Pharmacies, Green Cross Health said.


“Rako Science’s end-to-end solution, including standard operating procedures, infection control protocols and a robust training programme can be easily implemented in our pharmacies to ensure that we deliver this new exciting service to the highest standards possible” Mr Jones said.



73 views0 comments